YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Medtronic Quick-set Infusion Set
Medtronic Quick-Set Infusion Set Recall Lawyers
Keywords: Medtronic Lawsuit Quick Set Recall Lawyer
Diabetics who rely on Quick-set infusion sets used with Medtronic Inc.'s MiniMed Paradigm insulin pumps need to know that some of these infusion sets may not work. In July 2009, Medtronic initiated a recall of one lot of Quick-set infusion sets because the devices might not vent properly. This defect could interfere with the infusion set's ability to deliver insulin, leading to serious injury or even death.Thousands of diabetics use Quick-set infusion sets to help manage their disease. The malfunction of one of these devices could cause either too much or too little insulin to reach their blood stream. The results of such an event could be catastrophic. If you or someone you love were injured because of one of these devices, our Medtronic Quick-set infusion set recall lawyers want to hear from you.
Our Medtronic Quick-set infusion set injury lawyers are currently offering free case evaluations to anyone who was injured by one of the faulty insulin infusion sets. Please contact our office today to protect your legal rights.
Quick-set Infusion Set Recall
Medtronic's Quick-set infusion set is a thin plastic tube used to deliver insulin from the MiniMed Paradigm insulin pump to a diabetes patient. The device is typically replaced by the patient every three days.
In announcing the Quick-set infusion set recall, Medtronic said it had discovered that approximately two percent of “Lot 8” Quick-set infusion sets may not allow the insulin pump to vent air pressure properly. This could potentially result in the device delivering too much or too little insulin and may lead to serious injury or death. Patients were told to stop using the Quick-set infusion sets from "Lot 8" immediately.
Medtronic said its investigation of the venting problem revealed that a lubricant clogged the vents in some of the affected Quick-set infusion sets. To solve this situation, the lubricant has been eliminated from the manufacturing process.
The Quick-set infusion sets involved in this recall bear reference numbers MMT-396, MMT-397, MMT-398 and MMT-399 with lot numbers starting with the number “8.” The lot number (for example 8XXXXXX) is clearly marked on both the product box label, and on each individual infusion set package.
“Lot 8” Quick-set infusion sets were distributed in the United States, and in limited quantities in a small number of countries outside of the United States. The list of countries affected by this recall is available at www.medtronicdiabetes.com/lot8 or by contacting any Medtronic country office. No other Medtronic devices or infusion sets are involved in this recall.
Customers are being asked to return any affected infusion sets to the company. Medtronic is providing customers with replacement Quick-set infusion sets at no additional charge. Medtronic said it mailed out notification letters to customers, as well as one million replacement sets, which represent a 30-day supply.
Consequences of a Defective Quick-set Infusion Set
A defective Quick-set infusion set could cause a MiniMed Paradigm insulin pump to deliver too much or too little insulin to a diabetic patient. Insulin is a hormone naturally produced by the pancreas. It enables the body to use the sugar in food as a source of energy. Diabetics do not produce enough insulin, which makes it impossible for their bodies to regulate blood sugar.
If a defective Quick-set infusion set causes the delivery of too much insulin, insulin overdose could occur. Symptoms of an insulin overdose reflect very low blood sugar levels (hypoglycemia) and include headache, irregular heartbeat, increased heart rate or pulse, sweating, tremor, nausea, increased hunger, and anxiety. In very extreme cases, insulin overdose can cause death. If you suspect overdose, seek medical attention immediately.
Too little insulin can cause symptoms of high blood sugar (hyperglycemia) which include confusion, drowsiness, rapid breathing, fruity breath odor, increased urination or unusual thirst. If you fail to treat hyperglycemia, a condition called ketoacidosis (diabetic coma) could occur. Ketoacidosis is life-threatening.
Legal Help for Victims of Faulty Medtronic Quick-set Infusion Sets
Millions of people rely on Medtronic's Quick-set infusion sets to help manage their diabetes. Unfortunately, they may have suffered serious injuries if the set they were depending on was part of the Medtronic Quick-set infusion set recall.
Our law firm is currently investigating potential lawsuits against Medtronic on behalf of people injured by defective Quick-set infusion sets. To discuss your case with one of our Medtronic Quick-set infusion set recall lawyers, please fill out our online form or call 1-800 LAW INFO (1-800-529-4636) today.
Medtronic Quick-set Infusion SetRSS Feed
Medtronic Cardiac Rhythm Disease Management Site Gets FDA Warning Letter
Nov 19, 2009 | Parker Waichman Alonso LLP
Device maker giant, Medtronic, Inc., just announced that it received a warning letter from the U.S. Food & Drug Administration (FDA).According to the Twin Cities Business Journal, the letter came after an inspection of Medtronic’s Mounds View Cardiac Rhythm Disease Management site and concerned: “Corrective and preventative action and field-action timeliness, review and documentation of field action recommendations, supplier qualification and controls, and medical-device...
Grassley Putting More Heat on Spine Surgeon with Medtronic Ties
Sep 23, 2009 | Parker Waichman Alonso LLP
Senator Charles Grassley (R-Iowa) has expanded his investigation of Dr. David Polly. As we've reported previously, the relationship between Dr. Polly, head of spine surgery at the University of Minnesota, and Medtronic Inc. has been under scrutiny.Grassley's probe of Dr. Polly has already revealed that he had been paid $1.2 million by Medtronic between 2003 and 2007 for consulting work. Dr. Polly had come under fire in July for not disclosing his relationship with Medtronic...
Medtronic Advisory Says Some Concerto, Virtuoso Defibrillator Batteries May Deplete Prematurely
Sep 11, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. has issued an advisory for 6,300 Concerto CRT-D and Virtuoso implantable defibrillators. According to the advisory, the batteries on these devices may be depleted sooner than normalAccording to a letter sent to physicians, the devices affected by this advisory will give a 90-day advanced warning if the batteries are nearing depletion. Medtronic maintains that the battery issue does not compromise device functionality or affect therapy delivery. The company said...
Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products
Jul 16, 2009 | Parker Waichman Alonso LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to use their surgical ablation products to treat the heart-rhythm defect called atrial fibrillation, according to lawsuits recently unsealed in Texas. According to The Wall Street Journal, the lawsuits were filed by former employees of the companies.Allegations of kickbacks by medical device makers are nothing new. For example, in...
Defective Medical Devices
